March 24th 2023
The UK and Netherlands study assessed tumor response rates among 91 patients.
March 22nd 2023
March 21st 2023
Harnessing the Immune System to Fight Basal Cell Carcinoma: What are the Risks?January 4th 2023
In basal cell carcinoma, the most common type of skin cancer accounting for 80% of all non-melanoma skin cancers, one of the leading options for cases that fall into this category is targeted treatment with Hedgehog pathway inhibitors.